Venture Debt for Biotech Startups: Milestones, Risk, and Financing Structure
Biotech venture debt is often used by companies that expect to repay the loan through future equity funding, licensing or partnership income, product sales, or other strategic deals rather than current revenue. Because biotech companies often face long development timelines and uncertain outcomes, lenders structure these facilities to provide needed capital while managing clinical, regulatory, … Continued